GlaxoSmithKline (GSK) Fails to deliver data

Key failure to deliver metrics for GlaxoSmithKline:

• Last SEC data release: 2025-12-12
• Last 15 days FTD volume: HK$6.42 M
• Last 3 months FTD volume: HK$47.68 M
• Last 12 months FTD volume: HK$0.40 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for GlaxoSmithKline (GSK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022

GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
AstraZeneca AZN	HK$44.68 M	HK$0.11 B	🇬🇧 UK
Pfizer PFE	HK$27.68 M	HK$0.10 B	🇺🇸 USA
Merck MRK	HK$16.99 M	HK$0.16 B	🇺🇸 USA
Novartis NVS	HK$49.62 M	HK$0.10 B	🇨🇭 Switzerland
Sanofi SNY	HK$11.8 M	HK$69.68 M	🇫🇷 France
Teva Pharmaceutical Industries TEVA	HK$5.17 M	HK$40.03 M	🇮🇱 Israel
Dynavax Technologies DVAX	HK$0.56 M	HK$1.76 M	🇺🇸 USA